WJPR Citation New

  All Since 2011
 Citation  2903  2393
 h-index  27  24
 i10-index  68  60

Login

Best Paper Awards

World Journal of Pharmaceutical Research (WJPR) will give best paper award in every issue in the form of money along with certificate to promote research activity of scholar.
Best Paper Award :
Dr. Dhrubo Jyoti Sen
Download Article: Click Here

Search

Track Your Article

Abstract

THERAPEUTIC EFFICACY OF ABRAXANE

G. Vaishnavi*, S. L. Manjusha, N. Mohana Sree and sd. Abdul Jabbar Basha

Abstract

This article is related to therapeutic efficiency of ABRAXANE. ABRAXANE is a antitumor agent which is having hydrophobic nature, to overcome this property lipid based solvents are added as vehicles. ABRAXANE is the albumin-bounded 130° nanometer particle formulation paclitaxel. Since the standard dose of paclitaxel has lower incidences of toxicities, it is used in different types of malignant tumors. In the phase-III clinical trials nab – paclitaxel demonstrated higher response rates, better safety and side effects profile. Compared to conventional paclitaxel and improved survival in patients receiving it as second line therapy. ABRAXANE as superior efficacy to eliminate CSC’s in comparison with TAXOLS. The pharmacokinetic data of 260mg /m2 of ABRAXANE administered over 30 minutes was compared with pharmacokinetic data of 175mg/m2 of paclitaxel injection over 3 hours. The volume of distribution of ABRAXANE was higher (53%) than paclitaxel and the volume of clearance of ABRAXANE was found to be larger (43%) than paclitaxel injection.

Keywords: Abraxane, Paclitaxel, Tumor, Efficacy.


[Full Text Article]

Call for Paper

World Journal of Pharmaceutical Research (WJPR)
Read More

Email & SMS Alert

World Journal of Pharmaceutical Research (WJPR)
Read More

Article Statistics

World Journal of Pharmaceutical Research (WJPR)
Read More

Online Submission

World Journal of Pharmaceutical Research (WJPR)
Read More